John S. Montalbano, Director at AbCellera Biologics Inc. (ABCL), bought 50,000 shares at $2.30 ($115K) on 2025-03-10, disclosed to the SEC on 2025-03-10.
Open-market purchase of $115k ABCL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.30 | 25,000 | $57K | 50.0% |
| 2 | $2.30 | 25,000 | $58K | 50.0% |
| Total | $2.30 avg | 50,000 | $115K | 100% |
| Filing → |
| ABCL | BUY | 2025-11-26 | $179K | — | Filing → |
| ABCL | BUY | 2025-03-07 | $140K | — | Filing → |
| ABCL | BUY | 2023-11-08 | $137K | — | Filing → |